Orthostatic hypotension from sympathetic denervation in Parkinson’s disease

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Neurology

• Publication date

  2002-04-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1212/WNL.58.8.1247PMID 11971094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Autonomic Nervous System in Health and Disease

  2001cited by this paper
• NO modulates norepinephrine release in human skeletal muscle: implications for neural preconditioning.

  2001cited by this paper
• Fall Risk Factors in Parkinson's Disease

  2000cited by this paper
• Noninvasive detection of sympathetic neurocirculatory failure

  2000cited by this paper
• Scintigraphic differentiation between two forms of primary dysautonomia early after onset of autonomic dysfunction: value of cardiac and pulmonary iodine-123 MIBG uptake

  2000cited by this paper
• Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation.

  2000cited by this paper
• Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.

  2000cited by this paper
• Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific

  2000cited by this paper
• Differentiation of Parkinson's disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT.

  2000cited by this paper
• Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease and multiple system atrophy with autonomic failure

  2000cited by this paper
• Human papillomavirus detection to screen for cervical cancer.

  2000cited by this paper
• Suppressed sympathetic skin response in Parkinson disease

  2000cited by this paper
• [Worsened orthostatic hypotension due to levodopa administration in a case of Parkinson's disease].

  2000cited by this paper
• Cardiac Sympathetic Denervation in Parkinson Disease

  2000cited by this paper
• Differentiating Parkinson Disease From Multiple-System Atrophy by Measuring Cardiac Iodine-123 Metaiodobenzylguanidine Accumulation

  2000cited by this paper
• Cardiac uptake of [123I]MIBG separates Parkinson’s disease from multiple system atrophy

  1999cited by this paper
• Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value.

  1999cited by this paper
• Clinical and physiological characteristics of autonomic failure with Parkinson's disease

  1999cited by this paper
• 123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease

  1999cited by this paper
• Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases

  1999cited by this paper
• Postural instability in Parkinson's disease.

  1999cited by this paper
• Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy.

  1998cited by this paper
• Sympathetic skin response and cardiovascular autonomic function tests in Parkinson's disease.

  1998cited by this paper
• Cardiovascular autonomic dysfunction in parkinsonian patients.

  1998cited by this paper
• Impaired cardiac uptake of meta‐[123 I]iodobenzylguanidine in Parkinson's disease with autonomic failure

  1998cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology.

  1998cited by this paper
• Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm.

  1998cited by this paper
• Consensus statement on the diagnosis of multiple system atrophy

  1998cited by this paper
• Autonomic dysfunction in Parkinson's disease assessed by sympathetic skin response: a prospective clinical and neurophysiological trial on 50 patients

  1997cited by this paper
• 6-[18F]Fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function — studies in normal humans

  1997cited by this paper
• [Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson's disease: assessment of cardiac sympathetic denervation].

  1997cited by this paper
• Prevalence of orthostatic hypotension in Parkinson’s disease

  1997cited by this paper
• Sympathetic vasoconstrictor reflexes in Parkinson's disease with autonomic dysfunction

  1997cited by this paper
• [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].

  1997cited by this paper
• [Autonomic disorders in Parkinson's disease].

  1996cited by this paper
• Sympathetic skin response in Parkinson's disease

  1996cited by this paper
• Plasma catechols and monoamine oxidase metabolites in untreated Parkinson's and Alzheimer's diseases.

  1996cited by this paper
• Sympathetic skin response in parkinsonian patients.

  1996cited by this paper
• Mesenteric Organ Production, Hepatic Metabolism, and Renal Elimination of Norepinephrine and Its Metabolites in Humans

  1996cited by this paper
• Sympathetic discharge to mesenteric organs and the liver. Evidence for substantial mesenteric organ norepinephrine spillover.

  1996cited by this paper
• Autonomic disorders in Parkinson's disease.

  1995cited by this paper
• CSF and plasma concentrations of free norepinephrine, dopamine, 3,4‐dihydroxyphenylacetic acid (DOPAC), 3,4‐dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.

  1995cited by this paper
• Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.

  1994cited by this paper
• Relationship between arterial blood pressure disturbances and alpha adrenoceptor density.

  1994cited by this paper
• Small fibre function in primary autonomic failure

  1993cited by this paper
• Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans.

  1993cited by this paper
• Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease.

  1993cited by this paper
• Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.

  1993cited by this paper
• Sympathetic skin response and R–R interval variation in parkinson's disease

  1993cited by this paper
• Sympathetic Nervous Function in Human Heart as Assessed by Cardiac Spillovers of Dihydroxyphenylglycol and Norepinephrine

  1992cited by this paper
• Postural instability in Parkinson's disease.

  1992cited by this paper
• Regional extraction of circulating norepinephrine, DOPA, and dihydroxyphenylglycol in humans.

  1991cited by this paper
• Noradrenaline release in skeletal muscle and in adipose tissue studied by microdialysis.

  1991cited by this paper
• Autonomic nervous system disorders in Parkinson's disease.

  1991cited by this paper
• Fate of tritiated 6-fluorodopamine in rats: a false neurotransmitter for positron emission tomographic imaging of sympathetic innervation and function.

  1990cited by this paper
• [Orthostatic dysregulation in Parkinson syndrome. Results of a study of 250 patients].

  1990cited by this paper
• Blood pressure and plasma catecholamines in never‐treated parkinsonian patients

  1990cited by this paper
• Adrenergic supersensitivity in Parkinsonians with orthostatic hypotension

  1990cited by this paper
• Direct neurohumoral evidence for isolated sympathetic nervous system activation to skeletal muscle in response to cardiopulmonary baroreceptor unloading.

  1990cited by this paper
• Patterns of plasma levels of catechols in neurogenic orthostatic hypotension

  1989cited by this paper
• Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo.

  1989cited by this paper
• Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol.

  1988cited by this paper
• Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

  1988cited by this paper
• Postprandial and orthostatic hypotension in Parkinson's disease

  1987cited by this paper
• Correlation of the severity of autonomic dysfunction to cardiovascular reflexes and to plasma noradrenaline levels in Parkinson's disease.

  1987cited by this paper
• Plasma norepinephrine and epinephrine levels in essential hypertension.

  1984cited by this paper
• Plasma norepinephrine and epinephrine levels in essential hypertension.

  1984cited by this paper
• Age-dependence of hypertensive-normotensive differences in plasma norepinephrine.

  1983cited by this paper
• Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.

  1981cited by this paper
• Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man.

  1976cited by this paper
• Postural hypotension in idiopathic Parkinson's disease. Etiopathology.

  1976cited by this paper
• Levodopa-induced postural hypotension. Treatment with fludrocortisone.

  1975cited by this paper
• THE DISTRIBUTION OF LEWY BODIES IN THE CENTRAL AND AUTONOMIC NERVOUS SYSTEMS IN IDIOPATHIC PARALYSIS AGITANS

  1960cited by this paper

• Amplitude symbolic analysis: a tool for the evaluation of the autonomic function complementary to traditional symbolic approach

  2026cites this paper
• Update on Clinical Physiology and Pathomechanisms for Vestibulo-Autonomic Interplay

  2025cites this paper
• High prevalence of atrial conduction abnormalities in Lewy body disease – a marker of cardiac complications?

  2025cites this paper
• Intersection of Autonomic Dysfunction and Parkinson’s Disease: Insights Into Neurogenic and Classical Orthostatic Hypotension

  2025cites this paper
• Diagnostic and therapeutic challenges in PD-associated non-motor symptoms: the roles of neurologists and consultant physicians

  2024cites this paper
• Unveiling autonomic failure in synucleinopathies: Significance in diagnosis and treatment.

  2024cites this paper
• Sympathetic dysfunction as an early indicator of autonomic involvement in Parkinson’s disease

  2024cites this paper
• Comment to the article titled: sympathetic dysfunction as an early indicator of autonomic involvement in Parkinson’s disease

  2024cites this paper
• Cardiovascular dysautonomia and cognitive impairment in Parkinson's disease (Review)

  2024cites this paper
• Comorbidity of white matter lesions in parkinson’s disease: a study on risk factors and phenotypic differences

  2024cites this paper
• Association of Dizziness-Related Handicap or Disability with Clinical Features in Patients with Early Parkinson's Disease.

  2023cites this paper
• Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review

  2023cites this paper
• Thyroid [123I]MIBG uptake in Parkinson's disease and diabetes mellitus.

  2023cites this paper
• Orthostatic Hypotension in Multiple System Atrophy: Related Factors and Disease Prognosis

  2023cites this paper
• Pathological Pathways and Alpha-Synuclein in Parkinson's Disease: A View from the Periphery.

  2023cites this paper
• [Orthostatic hypotension in patients with Parkinson's disease].

  2023cites this paper
• What new can we learn from cardiac sympathetic neuroimaging in synucleinopathies?

  2022cites this paper
• Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD

  2022cites this paper
• Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy

  2022cites this paper
• Impact of subjective dizziness on motor and non-motor symptoms in patients with early stages of Parkinson's disease.

  2022cites this paper
• Impaired Cerebral Autoregulation in Parkinson's Disease: An Orthostatic Hypotension Analysis

  2022cites this paper
• Assessing autonomic dysfunction with functional imaging in Parkinson's disease

  2021cites this paper
• Distinct Patterns of Brain Metabolism in Patients at Risk of Sudden Unexpected Death in Epilepsy

  2021cites this paper
• General approach to patients with autonomic dysfunction in Parkinson's disease

  2021cites this paper
• Parkinsonism

  2021cites this paper
• Cardiovascular dysautonomia and cognition in Parkinson's Disease - a possible relationship.

  2021cites this paper
• Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson’s Disease—a Systematic Review

  2021cites this paper
• Cardiac Changes in Parkinson’s Disease: Lessons from Clinical and Experimental Evidence

  2021influential citation
• Autonomic viscero-visceral cardioneuropathy (literature review and own data)

  2021cites this paper
• Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients

  2021cites this paper
• What Is the Clinical Correlation of Cardiac Noradrenergic Denervation in Parkinson Disease?

  2021cites this paper
• Clinical Trials for Orthostatic Hypotension in Parkinson’s Disease and Other Synucleinopathies

  2021cites this paper
• Clinical Trials In Parkinson's Disease

  2021cites this paper
• Do indices of baroreflex failure and peripheral noradrenergic deficiency predict the magnitude of orthostatic hypotension in Lewy body diseases?

  2021cites this paper
• for Orthostatic in Parkinson’s and Other

  2020cites this paper
• Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective

  2020cites this paper
• Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges

  2020cites this paper
• Prodromal PD: A new nosological entity.

  2020cites this paper
• Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors

  2020cites this paper
• Comparison of symbolization strategies for complexity assessment of spontaneous variability in individuals with signs of cardiovascular control impairment

  2020cites this paper
• Heart rate variability and falls in Huntington’s disease

  2020cites this paper
• Synucleinopathies.

  2020cites this paper
• MPTP-Induced Impairment of Cardiovascular Function

  2020cites this paper
• Orthostatic Hypotension in Parkinson Disease.

  2020cites this paper
• Autonomic Dysfunction in the Synucleinopathies

  2020cites this paper
• Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists

  2020cites this paper
• Quantitative assessment of cardiovascular autonomic impairment in cancer survivors: a single center case series

  2020cites this paper
• Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration

  2020cites this paper
• The “Sick-but-not-Dead” Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases

  2020cites this paper
• Fatigability and Cardiorespiratory Impairments in Parkinson’s Disease: Potential Non-Motor Barriers to Activity Performance

  2020cites this paper
• Heart rate variability in patients with Parkinson ’ s disease complicated with orthostatic hypotension

  2019cites this paper
• Orthostatic hypotension and dementia incidence: links and implications

  2019cites this paper
• Pure Autonomic Failure.

  2019cites this paper
• The Central Autonomic Network and Regulation of Bladder Function

  2019cites this paper
• Autonomic dysfunction: Diagnosis and management.

  2019cites this paper
• Autonomic dysfunction in Parkinson disease and animal models

  2019cites this paper
• Parkinson’s disease with orthostatic hypotension: analyses of clinical characteristics and influencing factors

  2019cites this paper
• Molecular Imaging of Dementia With Lewy Bodies.

  2019cites this paper
• Orthostatic hypotension and dementia incidence: links and implications

  2019cites this paper
• Orthostatic hypotension and dementia incidence: links and implications

  2019cites this paper
• Orthostatic hypotension in Parkinson disease

  2019cites this paper
• Hemodynamic responses to an exercise stress test in Parkinson's disease patients without orthostatic hypotension.

  2019cites this paper
• Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging Features

  2018cites this paper
• Imaging the Autonomic Nervous System in Parkinson’s Disease

  2018cites this paper
• Roles of catechol neurochemistry in autonomic function testing

  2018cites this paper
• State of the art for diagnosis and treatment of orthostatic hypotension

  2018cites this paper
• Hemodynamic and Hormonal Responses to an Exercise Test in Parkinson's Disease Patients without Orthostatic Hypotension

  2018cites this paper
• The Motor, Cognitive, Affective, and Autonomic Functions of the Basal Ganglia

  2018cites this paper
• Heterogeneous pattern of autonomic dysfunction in Parkinson’s disease

  2018cites this paper
• Evaluation of the Effect of Vestibular Exercises on Dizziness and Postural Control in Parkinson Patients

  2018cites this paper
• Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies

  2018cites this paper
• Author response: Effects of orthostatic hypotension on cognition in Parkinson disease

  2017cites this paper
• Polymorphisms of COMT (c.649G>A), MAO-A (c.1460C>T), NET (c.1287G>A) Genes and the Level of Catecholamines, Serotonin in Patients with Parkinson's Disease

  2017cites this paper
• Imaging Parkinson’s disease below the neck

  2017cites this paper
• Role of peripheral vascular resistance as an indicator of cardiovascular abnormalities in patients with Parkinson's disease

  2017cites this paper
• Physiological Background of Reduced Cardiac 123 I-Meta-Iodobenzylguanidine Uptake

  2017cites this paper
• Decreased intestinal acetylcholinesterase in early Parkinson disease

  2017cites this paper
• [Nonmotor symptoms in Parkinson's disease].

  2017cites this paper
• Orthostatic dizziness in Parkinson's disease is attributed to cerebral hypoperfusion: A transcranial doppler study

  2017cites this paper
• Effects of orthostatic hypotension on cognition in Parkinson disease

  2017cites this paper
• 2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine PET

  2017cites this paper
• The heart of PD: Lewy body diseases as neurocardiologic disorders.

  2017cites this paper
• Ferroptosis and cell death mechanisms in Parkinson's disease

  2017cites this paper
• Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?

  2017cites this paper
• Sudden unexpected death in early Parkinson's disease: neurogenic or cardiac death?

  2017cites this paper
• Autonomic Dysfunction in Parkinson's Disease: Cardiovascular Symptoms, Thermoregulation, and Urogenital Symptoms.

  2017cites this paper
• Cardiovascular Autonomic Dysfunction in Mild and Advanced Parkinson’s Disease

  2016cites this paper
• Imaging Systemic Dysfunction in Parkinson’s Disease

  2016cites this paper
• Movement disorders.

  2016cites this paper
• Diagnosis: Warning signs

  2016cites this paper
• Alteration of Biological Rhythms in Diseases of the Central Dopaminergic System: Focus on Parkinson’s Disease

  2016cites this paper
• Clozapine in Parkinsonian Rest Tremor: A Review of Outcomes, Adverse Reactions, and Possible Mechanisms of Action

  2016influential citation
• Predictors of postprandial hypotension in elderly patients with de novo Parkinson’s disease

  2016cites this paper
• Loss of Autonomic Nervous System Control of Blood Pressure in Patients with Parkinson’s Disease.

  2016cites this paper
• General Autonomic Disorders

  2015cites this paper
• Cardiovascular and autonomic alterations in rats with Parkinsonism induced by 6-OHDA and treated with L-DOPA.

  2015cites this paper
• Chemoreflex and baroreflex alterations in Parkinsonism induced by 6-OHDA in unanesthetized rats.

  2015cites this paper
• Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.

  2015influential citation
• Orthostatic Hypotension in Parkinson Disease: How Much You Fall or How Low You Go?

  2015cites this paper
• Droxidopa in neurogenic orthostatic hypotension

  2015cites this paper